TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
DFTX

Definium Therapeutics, Inc.

Healthcare · Biotechnology · —

37.70$ -6.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow DFTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – –
– – – +21.5% +0.0% – – +21.6% -0.6% -83.3% -100.0%
– – – – – – +476.8% -67.9% +13.0% +9.2% +18.8%
– +1,216.5% -230.6% – – +891.7% -8.8% -301.2% – -153.2% –
– – +7,041.9% -51.4% -70.0% -100.0% – – – – –
– -21.6% -11,290.3% – -139.4% – – – – – –
– – – – – – – – – -49.9% +84.2%
– – – -92.8% -7.6% +33,435.5% +2.2% -40.2% -63.0% +1,058.9% +5.6%
– – -219.2% – -190.7% – -27.2% -83.9% -593.3% – -109.1%
– – – – – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?